Home/Filings/4/0001438133-24-000119
4//SEC Filing

BLICKENSTAFF KIM D 4

Accession 0001438133-24-000119

CIK 0001438133other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 7:21 PM ET

Size

10.2 KB

Accession

0001438133-24-000119

Insider Transaction Report

Form 4
Period: 2024-05-23
BLICKENSTAFF KIM D
DirectorPRESIDENT AND CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-24$51.73/sh+4,434$229,37117,848 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-05-244,4340 total
    Common Stock (4,434 underlying)
  • Award

    Restricted Stock Unit

    2024-05-23+4,3874,387 total
    Common Stock (4,387 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    205,190
Footnotes (5)
  • [F1]The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
  • [F2]Awarded on May 24, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
  • [F3]Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
  • [F4]RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
  • [F5]Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

Issuer

TANDEM DIABETES CARE INC

CIK 0001438133

Entity typeother

Related Parties

1
  • filerCIK 0001238913

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 7:21 PM ET
Size
10.2 KB